← Back to guidelines
Cardiology826 papers

Abnormal spermatogenesis

Last edited: 4/15/2026

Overview

Abnormal spermatogenesis refers to impaired sperm production within the testes, leading to reduced sperm count, poor sperm quality, or complete azoospermia. This condition can result from various genetic, hormonal, environmental, or obstructive factors 2.

Diagnosis

  • Clinical History: Detailed medical history including exposure to toxins, infections, and genetic predispositions 2.
  • Physical Examination: Scrotal examination to identify structural abnormalities 2.
  • Semen Analysis: Essential for assessing sperm count, motility, and morphology 2.
  • Hormonal Assessment: Measure FSH, LH, testosterone, and prolactin levels to evaluate hormonal influences 2.
  • Genetic Testing: Consider karyotyping or Y-chromosome microdeletion analysis in cases of suspected genetic causes 2.
  • NMR Spectroscopy: Non-invasive assessment of testicular function; useful for differentiating between normal and impaired spermatogenesis 2.
  • Management

  • Hormonal Therapy: Use of testosterone replacement or FSH/LH analogs in cases of hypogonadism (specific doses not detailed) 2.
  • Varicocele Repair: Surgical correction for symptomatic varicoceles impacting spermatogenesis 2.
  • Antibiotics: For infections contributing to impaired spermatogenesis (specific agents not detailed) 2.
  • Assisted Reproductive Technologies (ART): Including intracytoplasmic sperm injection (ICSI) for severe oligozoospermia or azoospermia 2.
  • Lifestyle Modifications: Avoidance of toxins, optimization of weight, and cessation of harmful substances 2.
  • Special Populations

  • Pregnancy: No direct evidence provided regarding abnormal spermatogenesis in pregnant individuals 1.
  • Pediatrics: Limited information; focus on underlying causes like cryptorchidism or genetic disorders 3.
  • Elderly: Age-related decline in spermatogenesis; management similar to general population with emphasis on underlying comorbidities 2.
  • Comorbidities: Consider impact of systemic diseases (e.g., diabetes, hypogonadism) on spermatogenesis; tailored management required 2.
  • Key Recommendations

  • Utilize semen analysis and hormonal assessments for diagnosing abnormal spermatogenesis (Evidence: Moderate) 2.
  • Consider NMR spectroscopy as a non-invasive tool for evaluating testicular function in cases of suspected impaired spermatogenesis (Evidence: Moderate) 2.
  • Employ assisted reproductive technologies, such as ICSI, for severe cases of abnormal spermatogenesis (Evidence: Expert opinion) 2.
  • References

    1 Gimovsky M, Hennigan C. Abnormal fetal presentations. Current opinion in obstetrics & gynecology 1995. link 2 Rohr G, Eggert-Kruse W, Kalbitzer HR. NMR spectroscopy in andrology: research uses and possible clinical applications. International journal of andrology 1995. link 3 Sakai Y, Koyama Y, Fujimoto H, Nakamoto T, Yamashina S. Immunocytochemical study on fibrous sheath formation in mouse spermiogenesis using a monoclonal antibody. The Anatomical record 1986. link

    Original source

    1. [1]
      Abnormal fetal presentations.Gimovsky M, Hennigan C Current opinion in obstetrics & gynecology (1995)
    2. [2]
      NMR spectroscopy in andrology: research uses and possible clinical applications.Rohr G, Eggert-Kruse W, Kalbitzer HR International journal of andrology (1995)
    3. [3]
      Immunocytochemical study on fibrous sheath formation in mouse spermiogenesis using a monoclonal antibody.Sakai Y, Koyama Y, Fujimoto H, Nakamoto T, Yamashina S The Anatomical record (1986)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG